HRA010097
Title:
mRNA changes with KY216 treatmentss
Release date:
2025-07-01
Description:
After administration of KY216 treatment, mRNAs with significantly elevated expression were screened and identified, and VASH2 identified as the research object for the next experiments to deeply explore the mechanism of the onset of action of KY216 drug
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cell line related study
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
XYZ-DAC
Contact person:
YUAN ZHENG XIA
Email:
xiayz@cpu.edu.cn
Description:
DAC members are from XYZ LABS, and the primary contact is XZY
Individuals & samples
Submitter:   XIA YUAN ZHENG / xiayz@cpu.edu.cn
Organization:   China Pharmaceutical University
Submission date:   2025-01-15
Requests:   -